T2 biosystems, inc. (TTOO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

579

580

151

437

343

245

-1

11

-

-

-

-

-

-

Research revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

331

504

839

659

668

804

564

178

-

-

-

-

-

-

Revenue:
Total revenue

2,545

3,069

1,677

1,804

1,785

1,792

2,466

3,931

2,311

1,661

1,108

956

941

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

910

1,084

990

1,096

1,011

1,049

564

189

-

-

-

-

91

120

Costs and expenses:
Cost of product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

2,171

1,894

1,781

1,026

910

829

2

1

-

-

-

-

-

-

Research and development

4,938

4,279

4,098

4,048

3,901

3,297

2,725

3,749

4,718

4,156

5,880

7,112

6,585

5,851

5,200

6,369

6,589

6,638

6,204

6,651

5,869

5,211

4,803

4,703

5,065

3,358

3,727

Selling, general and administrative

6,497

7,546

5,981

6,722

7,055

6,458

5,873

7,611

5,755

5,565

5,559

5,759

5,874

5,795

5,935

6,143

6,204

5,008

5,181

4,437

4,468

3,746

2,984

2,446

1,842

1,275

1,303

Total costs and expenses

16,106

15,436

14,023

15,590

15,344

15,386

11,640

14,818

13,746

16,027

13,545

14,860

14,086

13,817

13,029

14,293

13,819

12,556

12,214

11,088

10,338

8,957

7,787

7,149

6,907

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,633

5,030

Loss from operations

-13,561

-12,367

-12,346

-13,786

-13,559

-13,594

-9,174

-10,887

-11,435

-14,366

-12,437

-13,904

-13,145

-12,907

-11,945

-13,303

-12,723

-11,545

-11,165

-10,524

-10,149

-8,838

-7,787

-7,149

-6,907

-4,542

-4,910

Interest expense, net

-1,417

-1,690

-1,876

-2,000

-1,782

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-477

-

-

-304

-

-

-

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-80

-86

-100

-104

Other income, net

29

17

51

138

194

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6

-

13

0

-74

73

-

-

Net loss and comprehensive loss

-14,949

-14,041

-14,171

-15,647

-15,147

-15,149

-10,767

-12,324

-12,913

-18,193

-14,076

-15,456

-14,703

-14,549

-12,783

-14,046

-13,426

-12,032

-11,644

-10,995

-10,619

-9,076

-8,091

-7,303

-6,920

-4,642

-5,014

Comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,076

-8,091

-7,303

-6,920

-4,642

-5,014

Net loss

-14,949

-14,041

-14,171

-15,647

-15,147

-15,149

-10,767

-12,324

-12,913

-18,193

-14,076

-15,456

-14,703

-14,549

-12,783

-14,046

-13,426

-

-

-

-

-

-8,091

-7,303

-6,920

-4,642

-5,014

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

758

1,906

1,906

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,911

1,911

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,032

-11,644

-

-10,619

-9,076

-8,849

-9,209

-8,826

-6,553

-6,925

Net loss per share — basic and diluted

-0.22

-0.29

-0.31

-0.35

-0.34

-0.34

-0.25

-0.32

-0.36

-0.51

-0.45

-0.50

-0.48

-0.48

-0.51

-0.58

-0.55

-0.56

-0.57

-0.54

-0.53

9.16

-0.71

-6.35

-6.25

-4.69

-4.95

Weighted-average number of common shares used in computing net loss per share — basic and diluted

68,637

47,896

45,424

44,427

44,282

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,260

-

19,457

12,379

1,451

1,411

1,398

1,397

Product [Member]
Total revenue

1,045

1,562

1,177

1,274

1,314

1,319

1,218

1,220

1,048

1,335

739

735

631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product revenue

4,671

3,611

3,944

4,820

4,388

5,631

3,042

3,458

3,273

6,306

2,106

1,989

1,627

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research [Member]
Total revenue

-

294

56

71

142

473

1,248

2,711

1,263

326

369

221

310

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contribution [Member]
Total revenue

1,500

1,213

444

459

329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-